SMALL CAP IDEA: 'Neuro-psych' specialist Solvonis emerges in takeover wave

Daily Mail 1 min read 1 year ago

The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, highlight the growing interest in mental health treatment.
Read original Daily Mail